CITIUS ONCOLOGY INC
For the period ended Jun 30, 2024. Filed Aug 9, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2024 · Filed Aug 9, 2024
CTOR$0.51+1.9%Stored close · as of Nov 6, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
SIGNATURES
In accordance with the requirements of the Exchange Act, the registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
Date: August 9, 2024
| Citius Oncology, Inc. | |
| By: | /s/ Xiaofeng Yuan |
| Xiaofeng Yuan | |
| Chief Executive Officer and Chairman | |
| (Principal Executive Officer) | |
| By: | /s/ Taylor Zhang |
| Taylor Zhang | |
| Chief Financial Officer and Director | |
| (Principal Financial Officer and Accounting Officer) |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.